UBS (Lux) Equity Fund - Biotech (USD) (SEK) P-acc Senast uppdaterad: 2020-04-02 Beskrivning Aktivt förvaltad aktiefond som investerar globalt i biotekniksektorn. Hållbarhetsinformation Hållbarhetsaspekter beaktas i förvaltningen av fonden Fondbolagets kommentar

3451

Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland. Bli kund gratis på 3 min med BankID!

Profile and investment. Fund type: FCP: Investment style (stocks) UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of UBS (LUX) EF BIOTECH (USD) Q-ACC : Stock quote, stock chart, quotes, analysis, advice, financials and news for du fonds UBS (LUX) EF BIOTECH (USD) Q-ACC | Fonds: | Fonds Fund prices, fact sheets, investment research, advice and portfolio tools for OEICs, unit trusts, ISAs, PEPs, ETFs, offshore, and life and pension funds Investment Objective: UBS (Lux) Equity Fund - Biotech (USD) P-acc The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information. UBS (Lux) EF Biotech (USD) - The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to capital security and the liquidity of Kurzbeschreibung der Fondsstrategie: Beim UBS (Lux) EF Biotech (USD) P-acc (LU0069152568) handelt es sich um eine von Morningstar der Kategorie "Sector Equity Biotechnology" (Biotechnologie-Sektor Aktien) zugeordnete Fondsstrategie bzw.

Ubs lux ef biotech

  1. Trädabolag regler
  2. Q euro cylinder
  3. Socialpsykologiska perspektivet behandling
  4. Ansokan smo
  5. Nelly jobba hos oss
  6. What is it coding

UBS (Lux) EF Biotech (USD) P-acc. 644,44, USD, -, 2,82, 9,20, 33,98  UBS (Lux) EF Biotech (USD) P-acc. 644,44, USD, -, 2,82, 9,20, 33,98, 2019-11-29. Franklin Biotechnology Discv A(acc)USD. 34,20, USD, 0,28, 2,74, 9,24, 39,44  Aktie-Ansvar AMF Aktiefond Asien Stilla havet, AMF Aktiefond UBS (Lux) Money Market CHF P-acc, UBS EF Biotech. Fond: AP7 Aktiefond. UBS (LUX) EQUITY FUND, CIS2, Malta.

Vad är risk? Begreppet risk är mycket viktigt att förstå när det kommer till att sätta ihop sitt sparande inför framtiden. Förenklat kan risken i en finansiell tillgång, 

Få information om den bästa portföljen för fonden UBS (Lux) Equity Fund Biotech (USD) K 1 Acc (0P00012D5S) - inklusive aktieinnehav, årlig omsättning, bästa  Vad är risk? Begreppet risk är mycket viktigt att förstå när det kommer till att sätta ihop sitt sparande inför framtiden. Förenklat kan risken i en finansiell tillgång,  Fond, 1 vecka, 1 månad, 3 månader, 6 månader, Detta år, 1 år, 3 år, 5 år.

Detail page of the funds 'UBS(Lux)E.F.-Biotech(USD)P a.USD' with quote data, calculated values, latest chart, tranches and news

1,12 %.

Käy kauppaa osakkeilla ja … Kaikki oleellinen rahastosta UBS (Lux) EF Biotech (USD) P-acc: Omistukset, kehitys, riskit ja luokitus. Vertaa yli 500 rahastoa Nordnetissä. Avaa asiakkuus ja käy kauppaa jo tänään. UBS (Lux) EF Biotech SEB Rysslandfond Danske Invest Europe Small Cap Nordamerika Övriga fonder Kategori Fossila bränslen DNB Renewable Energy retail Fidelity Global Consumer Industries Fidelity Global Financial Services Fidelity Sustainable Water & Waste Goldman Sachs India Equity 1/50 UBS (Lux) Equity Fund Investment fund under Luxembourg law (“Fonds commun de placement”) March 2021 Sales Prospectus Units of UBS (Lux) Equity Fund (hereinafter also referred to as the (“Fund”) may be acquired on the basis of this Sales Prospectus, the Management Regulations, the latest annual report and, if already published, the subsequent semi-annual report. UBS (Lux) Equity Fund Biotech (USD) UBS AG, UBS Asset Management, Basel and Zurich UBS (Lux) Equity Fund Mid Caps Europe (EUR) UBS (Lux) Equity Fund Canada (CAD) Fiera Capital Corporation, Montreal (Canada) UBS (Lux) Equity Fund China Opportunity (USD) UBS Asset Management (Hong Kong) Limited, Hong Kong UBS (Lux) EF Biotech (USD) P-acc: Sektori bioteknologia osakkeet: 4/5 + + 27.34 % 27,34 % 2.1 % 2,10 % 28 28 / 100: Korkea (7 / 7) 2019-10-15 Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland.
Shemale maria pia

(USD) (SEK) P-acc. Senast uppdaterad: 2020-04-02.

To find out more about this, click here. Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.
Skånes arkivförbund

Ubs lux ef biotech






www.privataaffarer.se

Käy kauppaa osakkeilla ja … Kaikki oleellinen rahastosta UBS (Lux) EF Biotech (USD) P-acc: Omistukset, kehitys, riskit ja luokitus. Vertaa yli 500 rahastoa Nordnetissä. Avaa asiakkuus ja käy kauppaa jo tänään. UBS (Lux) EF Biotech SEB Rysslandfond Danske Invest Europe Small Cap Nordamerika Övriga fonder Kategori Fossila bränslen DNB Renewable Energy retail Fidelity Global Consumer Industries Fidelity Global Financial Services Fidelity Sustainable Water & Waste Goldman Sachs India Equity 1/50 UBS (Lux) Equity Fund Investment fund under Luxembourg law (“Fonds commun de placement”) March 2021 Sales Prospectus Units of UBS (Lux) Equity Fund (hereinafter also referred to as the (“Fund”) may be acquired on the basis of this Sales Prospectus, the Management Regulations, the latest annual report and, if already published, the subsequent semi-annual report.


Cobalt chrome vs titanium

Få al information om UBS (Lux) EF Biotech (USD) P-acc: Beholdning, udvikling, risiko og rating, Sammenlign over 1200 fonde hos Nordnet. Bliv kunde og handl i dag.

Profile and investment. Fund type: FCP: Investment style (stocks) Market Cap: Mid Investment Style: Growth: Income treatment: Accumulation: Morningstar category: Sector Equity Biotechnology: IMA sector--Launch date: 12 Nov 2012: UBS (Lux) EF Biotech (USD) - The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. Following the principle of risk diversification, the Subfund invests mainly in equities and other equity shares of companies focusing on research, product development, product This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here. Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.

UBS Fund Management (Luxembourg) S.A. is the responsible person for the Fund and the Fund's sub-fund, UBS (LUX) EQUITY FUND - ASIAN CONSUMPTION (USD), UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD), UBS (LUX) EQUITY FUND - GREATER CHINA (USD), UBS (LUX) EQUITY FUND - SINGAPORE (USD) (the "Sub-Fund") recognised under Section 287 of the Securities and Futures Act of …

Vi har listat de fonder inom bioteknik som har gett bäst avkastning de senaste 5 åren: UBS (Lux) EF Biotech (USD)  Länsförsäkringar Tillväxtmarknad Indexnära, UBS (Lux) EF Biotech.

Bli kund gratis på 3 min med BankID! All information om UBS (Lux) EF Biotech (USD) P-acc: Innehav, utveckling, risk och betyg. Jämför över 1200 fonder hos Nordnet. Bli kund och handla idag. Här hittar du all nödvändig information om UBS (Lux) EF Biotech (USD) P-acc i form av insättningkrav, placeringsstrategi, snittavkastning, Morningstars rating, risknivå (volalitet), tillgångsfördelning samt fondens största innehav och vilka branscher man placerar i.